We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Could treatment with R- HCVAD/R- MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? - Response to Landsburg et al.
- Authors
Westin, Jason; Oki, Yasuhiro; Fayad, Luis
- Abstract
A response from the author of an article in a 2013 issue regarding a study on diffuse large B cell lymphoma (DLBCL) patients treated with two different types of drug therapies consisting of rituximab in combination with different drugs including vincristine and doxorubicin is presented.
- Subjects
LYMPHOMA treatment; CANCER chemotherapy; RITUXIMAB
- Publication
British Journal of Haematology, 2014, Vol 165, Issue 1, p146
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/bjh.12704